150 related articles for article (PubMed ID: 26449497)
1. CD117 (KIT) is a useful immunohistochemical marker for differentiating porocarcinoma from squamous cell carcinoma.
Goto K; Takai T; Fukumoto T; Anan T; Kimura T; Ansai S; Oshitani Y; Murata Y; Sakuma T; Hirose T
J Cutan Pathol; 2016 Mar; 43(3):219-26. PubMed ID: 26449497
[TBL] [Abstract][Full Text] [Related]
2. Comparison of Immunohistochemical Expression of Cytokeratin 19, c-KIT, BerEP4, GATA3, and NUTM1 Between Porocarcinoma and Squamous Cell Carcinoma.
Goto K; Ishikawa M; Hamada K; Muramatsu K; Naka M; Honma K; Sugino T
Am J Dermatopathol; 2021 Nov; 43(11):781-787. PubMed ID: 33767067
[TBL] [Abstract][Full Text] [Related]
3. An immunohistochemical comparison of cytokeratin 7, cytokeratin 15, cytokeratin 19, CAM 5.2, carcinoembryonic antigen, and nestin in differentiating porocarcinoma from squamous cell carcinoma.
Mahalingam M; Richards JE; Selim MA; Muzikansky A; Hoang MP
Hum Pathol; 2012 Aug; 43(8):1265-72. PubMed ID: 22285043
[TBL] [Abstract][Full Text] [Related]
4. Utility of YAP1 and NUT immunohistochemistry in the diagnosis of porocarcinoma.
Russell-Goldman E; Hornick JL; Hanna J
J Cutan Pathol; 2021 Mar; 48(3):403-410. PubMed ID: 33222286
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemistry for CD117 (KIT) is effective in distinguishing cutaneous adnexal tumors with apocrine/eccrine or sebaceous differentiation from other epithelial tumors of the skin.
Goto K
J Cutan Pathol; 2015 Jul; 42(7):480-8. PubMed ID: 25864700
[TBL] [Abstract][Full Text] [Related]
6. Engrailed Homeobox 1 and Cytokeratin 19 Are Independent Diagnostic Markers of Eccrine Porocarcinoma and Distinguish It From Squamous Cell Carcinoma.
Miura K; Akashi T; Namiki T; Hishima T; Bae Y; Sakurai U; Murano K; Shiraishi J; Warabi M; Tanizawa T; Tanaka M; Bhunchet E; Kumagai J; Ayabe S; Sekiya T; Ando N; Shintaku H; Kinowaki Y; Tomii S; Kirimura S; Kayamori K; Yamamoto K; Ito T; Eishi Y
Am J Clin Pathol; 2020 Sep; 154(4):499-509. PubMed ID: 32556098
[TBL] [Abstract][Full Text] [Related]
7. Aberrant expression of p16 and RB protein in eccrine porocarcinoma.
Gu LH; Ichiki Y; Kitajima Y
J Cutan Pathol; 2002 Sep; 29(8):473-9. PubMed ID: 12207741
[TBL] [Abstract][Full Text] [Related]
8. Carcinoma and eccrine syringofibroadenoma: a report of five cases.
Bjarke T; Ternesten-Bratel A; Hedblad M; Rausing A
J Cutan Pathol; 2003 Jul; 30(6):382-92. PubMed ID: 12834488
[TBL] [Abstract][Full Text] [Related]
9. Perilipin and adipophilin expression in sebaceous carcinoma and mimics.
Boussahmain C; Mochel MC; Hoang MP
Hum Pathol; 2013 Sep; 44(9):1811-6. PubMed ID: 23642680
[TBL] [Abstract][Full Text] [Related]
10. BerEP4 is widely expressed in tumors of the sweat apparatus: a source of potential diagnostic error.
Afshar M; Deroide F; Robson A
J Cutan Pathol; 2013 Feb; 40(2):259-64. PubMed ID: 23194306
[TBL] [Abstract][Full Text] [Related]
11. [Clinicopathologic characterization of malignant mixed tumor of the skin accompanied by eccrine porocarcinoma].
Zhou XF; Yan QG; Guo XJ; Gou XD; Han JQ; Ye JL; Zhang HY; Wang FM
Zhonghua Bing Li Xue Za Zhi; 2018 Jul; 47(7):536-541. PubMed ID: 29996320
[No Abstract] [Full Text] [Related]
12. [Eccrine porocarcinoma of the scalp].
Ekmekcı S; Lebe B
Turk Patoloji Derg; 2013; 29(2):156-9. PubMed ID: 23661356
[TBL] [Abstract][Full Text] [Related]
13. Biphasic Sarcomatoid Porocarcinoma.
Le MD; Hassan K; Cassarino DS
Am J Dermatopathol; 2016 Jan; 38(1):73-6. PubMed ID: 25938848
[TBL] [Abstract][Full Text] [Related]
14. Altered Rb, p16, and p53 expression is specific for porocarcinoma relative to poroma.
Zahn J; Chan MP; Wang G; Patel RM; Andea AA; Bresler SC; Harms PW
J Cutan Pathol; 2019 Sep; 46(9):659-664. PubMed ID: 31012122
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemistry of eccrine poroma and porocarcinoma--more than acrosyringeal tumors?
Wollina U; Castelli E; Rülke D
Recent Results Cancer Res; 1995; 139():303-16. PubMed ID: 7541147
[TBL] [Abstract][Full Text] [Related]
16. DOG1, cyclin D1, CK7, CD117 and vimentin are useful immunohistochemical markers in distinguishing chromophobe renal cell carcinoma from clear cell renal cell carcinoma and renal oncocytoma.
Zhao W; Tian B; Wu C; Peng Y; Wang H; Gu WL; Gao FH
Pathol Res Pract; 2015 Apr; 211(4):303-7. PubMed ID: 25596994
[TBL] [Abstract][Full Text] [Related]
17. An unusual case of porocarcinoma arising on the scalp of a 22-year-old woman.
Jeon H; Smart C
Am J Dermatopathol; 2015 Mar; 37(3):237-9. PubMed ID: 25062260
[TBL] [Abstract][Full Text] [Related]
18. KIT (CD117) Expression in Benign and Malignant Sweat Gland Tumors.
Nishida H; Daa T; Kashima K; Arakane M; Urabe S; Yoshikawa Y; Gamachi A; Yokoyama S
Am J Dermatopathol; 2015 Dec; 37(12):898-905. PubMed ID: 25634571
[TBL] [Abstract][Full Text] [Related]
19. CD117 immunohistochemistry in sarcomatoid porocarcinoma.
Panse G; Subtil A
J Cutan Pathol; 2017 Jun; 44(6):596-598. PubMed ID: 28436041
[No Abstract] [Full Text] [Related]
20. p53 protein and proliferating cell nuclear antigen in eccrine poroma and porocarcinoma. an immunohistochemical study.
Tateyama H; Eimoto T; Tada T; Inagaki H; Nakamura T; Yamauchi R
Am J Dermatopathol; 1995 Oct; 17(5):457-64. PubMed ID: 8599450
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
